PPARGC1A and sarcopenia: Lastly, PGC1α suppression has been previously implicated in muscle atrophy, both during sarcopenia and in muscle wasting in chronic disease, whilst up-regulation of PGC1α has been associated with resistance to muscle atrophy (59,60).